Finer Jeffrey, the Chief Executive Officer of Septerna, Inc., recently disclosed several significant stock transactions in a filing with the Securities and Exchange Commission. This update, filed on November 16, 2026, includes details of both acquisitions and disposals of shares, which may affect investor perceptions and confidence in the company.

Background

Finer Jeffrey is the CEO of Septerna, Inc., a company classified under the Standard Industrial Classification of Pharmaceutical Preparations. The company operates in the life sciences sector and is incorporated in Delaware. Recent filings indicate that Septerna has been active in the market, reflecting ongoing developments within the pharmaceutical industry.

What the Filing Says

The filing reveals that on November 12, 2026, Jeffrey acquired 18,500 shares of Septerna's common stock at a price of $2.76 per share. Additionally, he disposed of shares in multiple transactions, including sales of 5,600 shares at an average price of $42.09, 5,300 shares at $43.10, and 2,800 shares at $44.23. Following these transactions, he retains ownership of 835,886 shares.

Impact

These transactions could influence various stakeholders, including investors and analysts monitoring Septerna's performance. As the CEO, Jeffrey's actions may signal confidence or concerns regarding the company's future, potentially impacting stock prices and investor sentiment.

What's Next

The filing does not say what happens next.